Japan

NSFに関する公表論文

ゲルべ研究所が実施したNSFに関連する研究報告について情報提供します。

2013年

Nephrogenic systemic fibrosis-ike effecs of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.

Fretellier N, Bouzian N, Parmentier N, Bruneval P, Jestin G, Factor C, Mandet C, Daubiné F, Massicot F, Laprévote O, Hollenbeck C, Port M, Idée JM, Corot C.

Toxicol Sci. 2013 Jan;131(1):259-70. Erratum in: Toxicol Sci. 2013 Mar;132(1):252.

2012年

Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.

Burtea C, Ballet S, Laurent S, Rousseaux O, Dencausse A, Gonzalez W, Port M, Corot C, Vander Elst L, Muller RN.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):e36-48.

Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.

Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaître M, Duquesnoy S, Garot J, Roques BP, Michel JB, Corot C, Ballet S.

Mol Pharm. 2012 Apr 2;9(4):850-61.

Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide.

Fretellier N, Idée J, Bruneval P, Guerret S, Daubiné F, Jestin G, Factor C, Poveda N, Dencausse A, Massicot F, Laprévote O, Mandet C, Bouzian N, Port M, Corot C.

Br J Pharmacol. 2012 Feb;165(4b):1151-62.

2011年

The role of phosphate on Omniscan(®) dechelation: an in vitro relaxivity study at pH 7.

Robic C, Catoen S, De Goltstein MC, Idée JM, Port M.

Biometals. 2011 Aug;24(4):759-68.

2009年

Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.

Idée JM, Port M, Dencausse A, Lancelot E, Corot C.

Radiol Clin North Am. 2009 Sep;47(5):855-69

2008年

Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.

Idée JM, Port M, Medina C, Lancelot E, Fayoux E, Ballet S, Corot C.

Toxicology. 2008 Jun 27;248(2-3):77-88.

Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.

Port M, Idée JM, Medina C, Robic C, Sabatou M, Corot C.

Biometals. 2008 Aug;21(4):469-90.